Fellowship · Los Angeles, CA
Sponsored by UCLA David Geffen School of Medicine/UCLA Medical Center
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Aaron Mochizuki
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method.
Nature biotechnology · 2025 · 88 citations · Donald Kohn
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
The New England journal of medicine · 2023 · 219 citations · Noah Federman
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · Noah Federman
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet (London, England) · 2023 · 108 citations · Theodore Moore, Donald Kohn
Successes and challenges in clinical gene therapy.
Gene therapy · 2023 · 127 citations ·
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.
Transplantation and cellular therapy · 2024 · 64 citations · David Buchbinder
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
The Journal of allergy and clinical immunology · 2023 · 103 citations · Donald Kohn